Literature DB >> 7796492

Thrombolysis for acute myocardial infarction. Why is there no extra benefit after hospital discharge?

F Van de Werf.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7796492     DOI： 10.1161/01.cir.91.12.2862

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Thrombolytic Therapy: The Treatment of Choice in Acute Myocardial Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

2.  Survival benefit of the late percutaneous coronary intervention in the patients after acute myocardial infarction who are or who are not treated with thrombolysis.

Authors:  Bozidarka Knezević; Nebojsa Bulatović; Natasa Belada; Vesna Ivanović; Sinisa Dragnić; Miroslav Rabrenović; Goran Nikolić; Ljilja Musić; Aneta Bosković
Journal:  Bosn J Basic Med Sci       Date:  2009-02       Impact factor: 3.363

3.  ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors:  C Baigent; R Collins; P Appleby; S Parish; P Sleight; R Peto
Journal:  BMJ       Date:  1998-05-02

Review 4.  A review of the long term effects of thrombolytic agents.

Authors:  R T van Domburg; E Boersma; M L Simoons
Journal:  Drugs       Date:  2000-08       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.